Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan.

Autoria(s): Zhao, Y.; McLaughlin, D.; McDermott, B.J.; Grieve, David
Data(s)

01/05/2010
Identificador

http://pure.qub.ac.uk/portal/en/publications/attenuation-of-doxorubicin-cardiotoxicity-and-nadph-oxidase-activation-by-the-at1-receptor-antagonist-losartan(29c044c6-e88d-4964-996c-b296c316e2ef).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Zhao , Y , McLaughlin , D , McDermott , B J & Grieve , D 2010 , ' Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. ' International Society for Heart Research World Congress , Kyoto , Japan , 01/05/2010 - 01/05/2010 , pp. S130-S130 .
Tipo

conferenceObject
Acesso ao item digital